SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-220539
Filing Date
2009-11-02
Accepted
2009-11-02 16:59:22
Documents
7
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 625827
2 EXCIPIENT MANUFACTURING AND SUPPLY AGREEMENT - KING PHARMACEUTICALS, INC. dex1055.htm EX-10.55 225939
3 SECOND AMENDMENT TO LEASE - DE ANZA ENTERPRISES dex1056.htm EX-10.56 11005
4 CERTIFICATION OF JAMES E. BROWN PURSUANT TO RULE 13A-14(A) SECTION 302 dex311.htm EX-31.1 9418
5 CERTIFICATION OF MATTHEW J. HOGAN PURSUANT TO RULE 13A-14(A) SECTION 302 dex312.htm EX-31.2 9490
6 CERTIFICATE OF JAMES E. BROWN PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3051
7 CERTIFICATE OF MATTHEW J. HOGAN PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3281
  Complete submission text file 0001193125-09-220539.txt   889374
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 091151727
SIC: 2834 Pharmaceutical Preparations